NLS Pharmaceutics Ltd (NLSP)
0.1839
+0.03
(+23.09%)
USD |
NASDAQ |
May 20, 13:21
NLS Pharmaceutics Total Return Level: 0.164 for May 17, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 17, 2024 | 0.164 |
May 16, 2024 | 0.1494 |
May 15, 2024 | 0.146 |
May 14, 2024 | 0.1509 |
May 13, 2024 | 0.1405 |
May 10, 2024 | 0.1393 |
May 09, 2024 | 0.1415 |
May 08, 2024 | 0.1386 |
May 07, 2024 | 0.1399 |
May 06, 2024 | 0.136 |
May 03, 2024 | 0.138 |
May 02, 2024 | 0.136 |
May 01, 2024 | 0.1339 |
April 30, 2024 | 0.1397 |
April 29, 2024 | 0.1416 |
April 26, 2024 | 0.1367 |
April 25, 2024 | 0.1324 |
April 24, 2024 | 0.125 |
April 23, 2024 | 0.1302 |
April 22, 2024 | 0.1299 |
April 19, 2024 | 0.1327 |
April 18, 2024 | 0.1327 |
April 17, 2024 | 0.133 |
April 16, 2024 | 0.137 |
April 15, 2024 | 0.1415 |
Date | Value |
---|---|
April 12, 2024 | 0.1496 |
April 11, 2024 | 0.1535 |
April 10, 2024 | 0.1496 |
April 09, 2024 | 0.1493 |
April 08, 2024 | 0.1406 |
April 05, 2024 | 0.1422 |
April 04, 2024 | 0.1542 |
April 03, 2024 | 0.16 |
April 02, 2024 | 0.1759 |
April 01, 2024 | 0.1724 |
March 28, 2024 | 0.18 |
March 27, 2024 | 0.1651 |
March 26, 2024 | 0.1748 |
March 25, 2024 | 0.1655 |
March 22, 2024 | 0.18 |
March 21, 2024 | 0.1699 |
March 20, 2024 | 0.157 |
March 19, 2024 | 0.2694 |
March 18, 2024 | 0.2698 |
March 15, 2024 | 0.309 |
March 14, 2024 | 0.3349 |
March 13, 2024 | 0.3414 |
March 12, 2024 | 0.33 |
March 11, 2024 | 0.3694 |
March 08, 2024 | 0.339 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.125
Minimum
Apr 24 2024
5.85
Maximum
Mar 12 2021
1.380
Average
1.03
Median
Jan 18 2022
Total Return Level Benchmarks
AC Immune SA | 3.18 |
CRISPR Therapeutics AG | 56.22 |
Addex Therapeutics Ltd | 8.79 |
Molecular Partners AG | 3.78 |
MoonLake Immunotherapeutics | 39.75 |